Gemin X Pharmaceuticals Funding Rounds

Add Funding

Date	Round	Amount	Investors
Aug 24, 2010	Series E	$ 8,000,000	Sanderling Ventures Caxton Advantage Life Sciences Fund
Apr 20, 2010	Series D	$ 16,000,000	Sanderling Ventures Caxton Advantage Life Sciences Fund
Jun 11, 2009	Debt Financing	$ 9,259,078
Jul 03, 2008	Series C	$ 38,000,000	SB Life Science Vantagepoint Capital Partners Sanderling Ventures Merlin Biomed HBM Partners Proquest Investments Pinnacle Ventures Ontario Teachers' Pension Plan HIG Capital Fonds de solidarité FTQ
Jul 19, 2007	Series A	Undisclosed amount